Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct;8(10):HC01-3.
doi: 10.7860/JCDR/2014/9133.4975. Epub 2014 Oct 20.

Anticancer drug induced palmar plantar erythrodysesthesia

Muthiah Palaniappan  1 , Sureshkumar Srinivasamurthy  2 , Biswajit Dubashi  3 , Adithan Chandrasekaran  4
Affiliations

Anticancer drug induced palmar plantar erythrodysesthesia

Muthiah Palaniappan et al. J Clin Diagn Res. 2014 Oct.

Abstract

Background: Palmar plantar erythrodysesthesia (PPE) is a dose limiting toxicity of anticancer agents. In some cases it may mandate for discontinuation of anticancer agents. Evaluation of data of PPE among reported adverse drug reactions (ADRs) from the Department of Medical Oncology could quantify the burden.

Aim: To evaluate and analyse the PPE among reported ADRs from medical Oncology.

Materials and methods: The data of all cases of reported PPE were collected during January 2012 to September 2013 and were analysed with WHO causality assessment scale. The severity was clinically graded. The follow-up data regarding outcome of ADRs were also noted.

Results: During the study period of 21 months a total of 1418 ADRs have been reported from 1076 patients. Among them PPE was reported from 31 cases (2.9%). Majority (32.2%) of these patients were on chemotherapy for breast cancer. Patient's age ranged from 17 to 68 y and the median age was 50 y. There were 18 female (58%) and 13 male patients (42%). Capecitabine was the leading drug involved in PPE, reported with 20 cases (64.5%), and followed by docetaxel with 5 cases (16.1%). Majority (67.7%) of the reactions was categorized as certain and 64.5% was grade II severity clinically.

Conclusion: Our findings show that PPE accounts for 2.9% of total reported ADRs from Medical Oncology during 21 months. Majority of the reactions were classified as certain. Capecitabine is commonly implicated drug.

Keywords: Adverse drug reaction; Anticancer drugs; Hand foot syndrome; Palmar plantar erythrodysesthesia; Pharmacoepidemiology; Pharmacovigilance.

PubMed Disclaimer

References

    1. Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia (‘hand-foot’) syndrome. Incidence, recognition and management. Am J Clin Dermatol. 2000;1(4):225–34. - PubMed
    1. Yvonne L, Paulo H. Management of hand-foot syndrome in patients treated with capecitabine (Xelodas) Eur J Oncol Nurs. 2004;8:31–S40. - PubMed
    1. Hueso L, Sanmartin O, Nagore E, Botella-Estrada R, Requena C, Llombart B, et al. Chemotherapy-Induced Acral Erythema: A Clinical and Histopathologic Study of 44 Cases. Actas Dermosifiliogr. 2008;99:281–90. - PubMed
    1. Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf. 1997;17(6):374–89. - PubMed
    1. Janusch M, Fischer M, Marsch WCh, Holzhausen HJ, Kegel T, Helmbold P. The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy. Eur J Dermatol. 2006;16(5):494–99. - PubMed

LinkOut - more resources